CLINICAL EVALUATION OF URACIL MUSTARD.
D000740:Anemia; D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D002699:Chlorambucil; D005260:Female; D006689:Hodgkin Disease; D006801:Humans; D007680:Kidney Neoplasms; D007938:Leukemia; D007945:Leukemia, Lymphoid; D008175:Lung Neoplasms; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009369:Neoplasms; D009588:Nitrogen Mustard Compounds; D010051:Ovarian Neoplasms; D012509:Sarcoma; D014116:Toxicology; D014499:Uracil Mustard
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D002699:Chlorambucil; D014499:Uracil Mustard
ANEMIA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHLORAMBUCIL; HODGKIN'S DISEASE; KIDNEY NEOPLASMS; LEUKEMIA, LYMPHOCYTIC; LUNG NEOPLASMS; LYMPHOSARCOMA; NITROGEN MUSTARD COMPOUNDS; OVARIAN NEOPLASMS; SARCOMA, RETICULUM CELL; TOXICOLOGIC REPORT; URACIL MUSTARD